• Outpatient Treatment Without Antibiotics or with Ciprofloxacin, Cefuroxime, Cefditoren Pivoxil, Amoxicillin/Clavulanic Acid, and Metronidazole in Adults with Acute Uncomplicated Diverticulitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Indocyanine Green and Near-Infrared Fluorescence for Lymph Node Removal in Children with Renal Tumours or Paratesticular Rhabdomyosarcoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands
  • A study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria
  • A study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis

    Recruiting

    1 1
    Investigated Drugs:
    Poland
  • A study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease

    Recruiting

    3 1
    Belgium France Germany Italy The Netherlands Poland +2
  • Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Poland
  • Comparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Hungary +5
  • A study to evaluate the effectiveness of methotrexate in preventing the recurrence of dermatological vulvar intraepithelial neoplasia in women with lichen sclerosus.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

    Recruiting

    3 1 1
    Investigated Diseases:
    Belgium Denmark France Germany Italy The Netherlands +1
  • A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Czechia Denmark Finland France Germany +4

powered by